Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials

W Zając, J Dróżdż, W Kisielewska, W Karwowska… - Cancers, 2023 - mdpi.com
Simple Summary Dedifferentiated chondrosarcoma is a rare type of cancer that is very
aggressive and has a poor prognosis with poor survival rates. This disease can affect …

A promising role of noble metal NPs@ MOFs in chondrosarcoma management

Z Huang, K Tian, Y Xue, F Luo - Nanoscale, 2025 - pubs.rsc.org
Chondrosarcoma, a challenging and malignant neoplasm originating from cartilage cells,
poses significant diagnostic and therapeutic hurdles due to its resistance to conventional …

Chondrosarcoma of the femur: is local recurrence influenced by the presence of an extraosseous component?

MK Laitinen, MC Parry, GV Morris, RJ Grimer… - Cancers, 2024 - mdpi.com
Simple Summary This study focused on conventional central chondrosarcoma (CS) in the
femur, investigating the impact of an extraosseous tumor component on local recurrence …

The stimulation of exosome generation by visfatin polarizes M2 macrophages and enhances the motility of chondrosarcoma

CY Song, CY Wu, CY Lin, CH Tsai… - Environmental …, 2024 - Wiley Online Library
Chondrosarcoma is a malignant bone tumor that arises from abnormalities in cartilaginous
tissue and is associated with lung metastases. Extracellular vesicles called exosomes are …

Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma

V Ingangi, A De Chiara, G Ferrara, M Gallo… - Cells, 2024 - mdpi.com
Chondrosarcoma (ChS), a malignant cartilage-producing tumor, is the second most
frequently diagnosed osseous sarcoma after osteosarcoma. It represents a very …

Update of cartilaginous tumours according to the WHO classification 2020

S Gomez-Pena, ÁR de Eusebio, JA García… - Radiología (English …, 2024 - Elsevier
Cartilaginous tumours are a large and heterogeneous group of neoplasms characterised by
the presence of a chondroid matrix, with lobular growth and arcuate, ring-like or popcorn-like …

Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma

CY Song, SL Hsieh, SY Yang, CY Lin… - International Journal of …, 2024 - mdpi.com
Chondrosarcoma is a malignant bone tumor that arises from abnormalities in cartilaginous
tissue and is associated with lung metastases. Lymphangiogenesis plays an essential role …

Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials

M Dudzisz-Śledź, M Kondracka, M Rudzińska… - Cancers, 2023 - mdpi.com
Simple Summary Mesenchymal chondrosarcoma (MCS) is a subtype of chondrosarcoma
with rare occurrence and poor survival rates. MCS stains positive for S-100 and SOX9 as …

Development and validation of a nomogram for predicting prognosis of high-grade chondrosarcoma: A surveillance, epidemiology, and end results-based population …

Y Sun, C Ouyang, Y Zhang, Y Li, Y Liu… - Journal of …, 2023 - journals.sagepub.com
Background The incidence of chondrosarcoma is increasing every year, and the treatment
and prognosis of patients with high-grade chondrosarcoma are becoming more and more …

Transcriptomic data integration and analysis revealing potential mechanisms of doxorubicin resistance in chondrosarcoma cells

JC Chen, MS Chen, SK Jiang, CY Eaw, YJ Han… - Biochemical …, 2025 - Elsevier
Chondrosarcoma is a type of bone cancer that originates from cartilage cells. In clinical
practice, surgical resection is the primary treatment for chondrosarcoma, but chemotherapy …